Melanotan I (10mg)

Selective MC1R Agonist (Afamelanotide)

Melanotan I (10mg) is supplied in Australia by Aussie Peptides with fast domestic shipping to all states and territories.

Melanotan I — also known as afamelanotide or MT1 — is a selective melanocortin-1 receptor (MC1R) agonist studied for melanin synthesis. Unlike Melanotan II (MT2), which is non-selective across MC1R/MC3R/MC4R/MC5R, MT1 acts primarily on MC1R and has a longer half-life. It is the same compound used in afamelanotide-based therapies clinically approved overseas for severe light-sensitivity conditions.

Key Research Areas

• Melanogenesis — Stimulates melanin synthesis without UV exposure
• Extended Half-Life — Significantly longer half-life than MT2, sustaining pigmentation studies over longer periods
• Receptor Selectivity — Primarily MC1R-targeted; minimal MC3R/MC4R/MC5R activity
• UV Photoprotection — Higher melanin levels studied for reduced UV-induced skin damage

Supplied as lyophilized powder at 99.553% purity as reported on the CoA, verified by HPLC and mass spectrometry. 10mg per vial. Fast domestic shipping across Australia, with batch-specific CoA information available in our CoA Library.

⚠ For in-vitro research and laboratory use only. Not for human consumption.